Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

LY4086940

A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes

Eli Lilly · Phase 2 · Not yet recruiting · Enrollment 460

NCT07890376

ArmPopulationDoseWeeksEstimandWeight change
LY4086940 Dose 1Obesity or overweightn/rn/rn/rn/r
LY4086940 Dose 2Obesity or overweightn/rn/rn/rn/r
LY4086940 Dose 3, Titration Schedule AObesity or overweightn/rn/rn/rn/r
LY4086940 Dose 3, Titration Schedule BObesity or overweightn/rn/rn/rn/r
LY4086940 Dose 4Obesity or overweightn/rn/rn/rn/r
LY4086940 Dose 5Obesity or overweightn/rn/rn/rn/r
LY4086940 Dose 6, Titration Schedule AObesity or overweightn/rn/rn/rn/r
LY4086940 Dose 6, Titration Schedule BObesity or overweightn/rn/rn/rn/r
LY4086940 Dose 6, Titration Schedule CObesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r